Nexus
About Nexus
Nexus is an AI-based precision dosing algorithm that minimizes drug resistance and reduces negative side effects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $100.0K
- Funding stage: Seed
- Last round: Seed (Oct 2020)
Industries & Categories
Artificial Intelligence (AI)
Canonical: https://fsome.com/organization/nexus-130572 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.